Late Events in Retrovirus Assembly
逆转录病毒组装中的晚期事件
基本信息
- 批准号:7623521
- 负责人:
- 金额:$ 33.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-15 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:Binding ProteinsBiogenesisCell physiologyCellsClathrinDiseaseEndocytosisEndosomesEventFundingGoalsGrantHIVHIV-1InfectionLifeMediatingMultivesicular BodyPathway interactionsProcessProteinsRecruitment ActivityRequest for ApplicationsRetroviridaeRoleSiteSorting - Cell MovementStagingSystemUbiquitinVacuolar Protein SortingViralVirionVirusWorknovelparticlepublic health relevancetherapeutic targettraffickingubiquitin ligase
项目摘要
DESCRIPTION (provided by applicant): In this competing renewal application we request support for our studies on late events in retrovirus assembly. In the previous funding cycle, we identified and characterized several cellular proteins that are recruited to sites of retrovirus assembly by viral late budding (L)-domains. These proteins are either (i) components of the class E vacuolar protein sorting (VPS) pathway that is normally involved in the manipulation of endosomes and multivesicular bodies (MVB) or (ii) ubiquitin ligases. For several of these factors we were able to demonstrate a critical role in the release of infectious retroviral particles. Several mechanistic questions remain, however, and recently we have identified additional cellular factors that seem very likely to be involved in the late stages of the construction and release of retrovirus particles, and/or endosome/MVB biogenesis. In the next grant period, we will attempt to elucidate how previously defined and newly identified cellular factors participate in the late stages of retrovirus assembly and related cellular functions by pursuing two specific aims. Specific Aim 1 is to understand how specific endosomal proteins are incorporated into HIV-1 particles and their role in generating infectious virions. Specific aim 2 is to determine the role of ubiquitin, ubiquitin ligases and novel ubiquitin ligase binding proteins, discovered during the previous funding period, in retroviral budding and trafficking of endocytosed proteins. Execution of these two aims should result in significant progress toward our long term goal of understanding how cellular and viral factors cooperate in the construction of complete, infectious retroviral particles. Understanding these events could potentially provide new opportunities to interfere in these processes for the treatment of diseases caused by HIV and other enveloped viruses. Public health relevance: Many enveloped viruses, for example HIV-1, are responsible for life threatening infections. To spread from cell to cell they make use of cellular proteins to facilitate the release of accurately assembled virus particles. Understanding how this system works could give opportunities to intervene with targeted therapeutics.
描述(由申请人提供):在本竞争性续展申请中,我们请求支持我们对逆转录病毒组装晚期事件的研究。在上一个资助周期中,我们确定并表征了几种细胞蛋白,这些蛋白通过病毒晚期出芽(L)结构域被招募到逆转录病毒组装位点。这些蛋白质是(i)E类空泡蛋白分选(VPS)途径的组分,其通常参与内体和多泡体(MVB)的操纵,或(ii)泛素连接酶。对于这些因素中的几个,我们能够证明在感染性逆转录病毒颗粒的释放中起关键作用。然而,仍然存在一些机制问题,最近我们已经确定了额外的细胞因子,似乎很可能参与逆转录病毒颗粒的构建和释放的后期阶段,和/或内体/MVB生物合成。在下一个资助期内,我们将试图阐明以前定义和新发现的细胞因子如何参与逆转录病毒组装的后期阶段和相关的细胞功能,通过追求两个具体的目标。具体目标1是了解特定的内体蛋白如何被纳入HIV-1颗粒及其在产生感染性病毒粒子中的作用。具体目标2是确定泛素,泛素连接酶和新的泛素连接酶结合蛋白的作用,发现在以前的资助期间,在逆转录病毒出芽和运输的内吞蛋白。这两个目标的实现将使我们的长期目标取得重大进展,即了解细胞和病毒因子如何合作构建完整的感染性逆转录病毒颗粒。了解这些事件可能会提供新的机会来干预这些过程,以治疗由HIV和其他包膜病毒引起的疾病。公共卫生相关性:许多包膜病毒,例如HIV-1,是威胁生命的感染的原因。为了在细胞间传播,它们利用细胞蛋白来促进精确组装的病毒颗粒的释放。了解这个系统是如何工作的,可以为靶向治疗提供干预机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul D. Bieniasz其他文献
689. Restriction Profiles of Primate TRIM5α on FIV
- DOI:
10.1016/j.ymthe.2006.08.767 - 发表时间:
2006-01-01 - 期刊:
- 影响因子:
- 作者:
Douglas E. Dylla;Melissa A. Hickey;Theodora Hatziioannou;Paul D. Bieniasz;Paul B. McCray - 通讯作者:
Paul B. McCray
Functional anatomy of zinc finger antiviral protein complexes
锌指抗病毒蛋白复合物的功能解剖学
- DOI:
10.1038/s41467-024-55192-z - 发表时间:
2024-12-30 - 期刊:
- 影响因子:15.700
- 作者:
Jennifer A. Bohn;Jennifer L. Meagher;Matthew A. Takata;Daniel Gonçalves-Carneiro;Zoe C. Yeoh;Melanie D. Ohi;Janet L. Smith;Paul D. Bieniasz - 通讯作者:
Paul D. Bieniasz
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress
HIV-1 和埃博拉病毒编码小肽基序,招募 Tsg101 到颗粒组装位点以促进外排
- DOI:
10.1038/nm1201-1313 - 发表时间:
2001-12-01 - 期刊:
- 影响因子:50.000
- 作者:
Juan Martin-Serrano;Trinity Zang;Paul D. Bieniasz - 通讯作者:
Paul D. Bieniasz
Paul D. Bieniasz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul D. Bieniasz', 18)}}的其他基金
Broad neutralization of pandemic threat coronaviruses
广泛消除大流行威胁冠状病毒
- 批准号:
10327989 - 财政年份:2022
- 资助金额:
$ 33.91万 - 项目类别:
Broad neutralization of pandemic threat coronaviruses
广泛消除大流行威胁冠状病毒
- 批准号:
10841237 - 财政年份:2022
- 资助金额:
$ 33.91万 - 项目类别:
Coronavirus neutralizing antibody epitopes and immunogens
冠状病毒中和抗体表位和免疫原
- 批准号:
10327993 - 财政年份:2022
- 资助金额:
$ 33.91万 - 项目类别:
Coronavirus neutralizing antibody epitopes and immunogens
冠状病毒中和抗体表位和免疫原
- 批准号:
10841241 - 财政年份:2022
- 资助金额:
$ 33.91万 - 项目类别:
Host protein targets of HIV-1 Vpr in gene expression, cell cycle and innate immunity
HIV-1 Vpr 在基因表达、细胞周期和先天免疫中的宿主蛋白靶点
- 批准号:
10265576 - 财政年份:2020
- 资助金额:
$ 33.91万 - 项目类别:
Host protein targets of HIV-1 Vpr in gene expression, cell cycle and innate immunity
HIV-1 Vpr 在基因表达、细胞周期和先天免疫中的宿主蛋白靶标
- 批准号:
10681282 - 财政年份:2020
- 资助金额:
$ 33.91万 - 项目类别:
Host protein targets of HIV-1 Vpr in gene expression, cell cycle and innate immunity
HIV-1 Vpr 在基因表达、细胞周期和先天免疫中的宿主蛋白靶点
- 批准号:
10468987 - 财政年份:2020
- 资助金额:
$ 33.91万 - 项目类别:
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle
在 HIV-1 生命周期早期从功能上定义 HIV 与宿主的相互作用
- 批准号:
10594493 - 财政年份:2020
- 资助金额:
$ 33.91万 - 项目类别:
相似国自然基金
UMSC-Exo通过调控Ribosome biogenesis诱导心肌再生的策略及机制研究
- 批准号:82370264
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
活体动物线粒体biogenesis、fission及fusion对肝脏再生中能量供应影响机制的研究
- 批准号:81470878
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
相似海外基金
白血病幹細胞におけるRibosomal biogenesisの解明と治療戦略の構築
白血病干细胞核糖体生物发生的阐明和治疗策略的开发
- 批准号:
24H00639 - 财政年份:2024
- 资助金额:
$ 33.91万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Biogenesis of the mitochondrial beta-barrel membrane protein at the intermembrane space.
膜间空间线粒体β-桶膜蛋白的生物发生。
- 批准号:
24K18071 - 财政年份:2024
- 资助金额:
$ 33.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New mechanisms regulating the biogenesis of extracellular vesicles
调节细胞外囊泡生物发生的新机制
- 批准号:
DP240101427 - 财政年份:2024
- 资助金额:
$ 33.91万 - 项目类别:
Discovery Projects
DEL-1 Promotes Biogenesis of Mineralizing Extracellular Vesicles by Mediating Intracellular Calcium Signaling
DEL-1 通过介导细胞内钙信号传导促进矿化细胞外囊泡的生物合成
- 批准号:
24K19876 - 财政年份:2024
- 资助金额:
$ 33.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
MFB: Characterization of the Biogenesis, Uptake, and Cellular Response to the Ribonucleoprotein Cargoes of Extracellular Vesicles using EV-CLASP
MFB:使用 EV-CLASP 表征细胞外囊泡核糖核蛋白货物的生物合成、摄取和细胞反应
- 批准号:
2330665 - 财政年份:2024
- 资助金额:
$ 33.91万 - 项目类别:
Standard Grant
Mechanisms of PIKII-dependent transport during secretory granule biogenesis
分泌颗粒生物发生过程中 PIKII 依赖性运输的机制
- 批准号:
490594 - 财政年份:2023
- 资助金额:
$ 33.91万 - 项目类别:
Operating Grants
Changes in structure and biogenesis of Gram-negative envelope following a polymyxin challenge
多粘菌素攻击后革兰氏阴性包膜的结构和生物发生的变化
- 批准号:
BB/X000370/1 - 财政年份:2023
- 资助金额:
$ 33.91万 - 项目类别:
Research Grant
MITOCHONDRIA REDOX BIOGENESIS AND METABOLIC RAMAN IMAGING IN INSULIN SIGNALLING
胰岛素信号传导中的线粒体氧化还原生物发生和代谢拉曼成像
- 批准号:
2883511 - 财政年份:2023
- 资助金额:
$ 33.91万 - 项目类别:
Studentship
Molecular Mechanisms of Mitochondrial Biogenesis
线粒体生物发生的分子机制
- 批准号:
10735778 - 财政年份:2023
- 资助金额:
$ 33.91万 - 项目类别: